Home Tags Gilead Sciences

Tag: Gilead Sciences

Lenacapavir is an antiretroviral medication used to treat and prevent HIV-1 infection. It works by inhibiting HIV's capsid protein, disrupting multiple steps in the virus's lifecycle, and can be administered as a long-acting subcutaneous injection given every six months, after an initial oral loading dose. (Picture by Olan Stock via DepositPhotos.com)

New long-acting HIV shot Lenacapavir gets rapid green light in Zimbabwe

Nyashadzashe Ndoro - 0
A young African female research scientist and senior male supervisor analyzing microscope slides (Picture by Wirestock via DepositPhotos.com)

Zimbabwe selected for global rollout of breakthrough HIV prevention drug

Nyashadzashe Ndoro - 25